ATE308614T1 - Durch pflanzen hergestelltes rekombinantes kollagen, verfahren zu ihrer herstellung und verwendung - Google Patents

Durch pflanzen hergestelltes rekombinantes kollagen, verfahren zu ihrer herstellung und verwendung

Info

Publication number
ATE308614T1
ATE308614T1 AT97952089T AT97952089T ATE308614T1 AT E308614 T1 ATE308614 T1 AT E308614T1 AT 97952089 T AT97952089 T AT 97952089T AT 97952089 T AT97952089 T AT 97952089T AT E308614 T1 ATE308614 T1 AT E308614T1
Authority
AT
Austria
Prior art keywords
plants
derived proteins
production
recombinant collagen
collagen produced
Prior art date
Application number
AT97952089T
Other languages
English (en)
Inventor
Veronique Gruber
Jean-Yves Exposito
Florence Ruggiero
Jeanne Comte
Robert Garrone
Bertrand Merot
Philippe Bournat
Original Assignee
Meristem Therapeutics S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9499306&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE308614(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Meristem Therapeutics S A filed Critical Meristem Therapeutics S A
Application granted granted Critical
Publication of ATE308614T1 publication Critical patent/ATE308614T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97952089T 1996-12-17 1997-12-17 Durch pflanzen hergestelltes rekombinantes kollagen, verfahren zu ihrer herstellung und verwendung ATE308614T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9616224A FR2757874B1 (fr) 1996-12-17 1996-12-17 Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations
PCT/FR1997/002331 WO1998027202A1 (fr) 1996-12-17 1997-12-17 Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations

Publications (1)

Publication Number Publication Date
ATE308614T1 true ATE308614T1 (de) 2005-11-15

Family

ID=9499306

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97952089T ATE308614T1 (de) 1996-12-17 1997-12-17 Durch pflanzen hergestelltes rekombinantes kollagen, verfahren zu ihrer herstellung und verwendung

Country Status (9)

Country Link
US (2) US6617431B1 (de)
EP (1) EP0951537B1 (de)
JP (1) JP2001507573A (de)
AT (1) ATE308614T1 (de)
AU (1) AU5563798A (de)
CA (1) CA2274807A1 (de)
DE (1) DE69734528T2 (de)
FR (1) FR2757874B1 (de)
WO (1) WO1998027202A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834909A1 (de) * 1998-08-03 2000-02-17 Mpb Cologne Gmbh Molecular Pla Faserproteine und ihre Herstellung
US6638907B1 (en) 1999-04-30 2003-10-28 Biostratum, Inc. Laminin 8 and methods for its use
EP1232182B1 (de) * 1999-11-12 2007-10-03 Fibrogen, Inc. Rinder-kollagen und verfahren zur herstelling rekombinantes gelatin
EP2011874A1 (de) * 1999-11-12 2009-01-07 Fibrogen, Inc. Rekombinante Gelatine in Impfstoffen
US6992172B1 (en) 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
AU2005246967B2 (en) * 1999-11-12 2008-09-04 Fibrogen, Inc. Recombinant gelatins
FR2807436B1 (fr) * 2000-04-10 2002-05-24 Meristem Therapeutics Methode d'obtention de fibres d'un polypeptide collagenique recombinant non-hydroxyle, et fibres de polypeptide collagenique recombinant non-hydroxyle ainsi obtenues
FR2854328B1 (fr) * 2003-04-29 2006-08-04 Rocher Yves Biolog Vegetale Composition cosmetique ou dermatologique ou pharmaceutique contenant un facteur de croissance du type vegetal de nature peptidique
US7268116B2 (en) * 2003-10-02 2007-09-11 Genhunter Corp. Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins
CN101065491B (zh) 2004-09-29 2012-01-11 胶原植物有限公司 生产胶原的植物及其生成和使用方法
US8455717B2 (en) 2004-09-29 2013-06-04 Collplant Ltd. Collagen producing plants and methods of generating and using same
EP1904638A2 (de) 2005-07-18 2008-04-02 Metabogal Ltd. Mukosale oder enterale verabreichung biologisch aktiver makromoleküle
EP1951762B1 (de) 2005-10-03 2018-02-07 PINSKY, Mark A. Zusammensetzungen und verfahren zur verbesserten hautpflege
US20080081353A1 (en) * 2006-09-29 2008-04-03 Universite Laval Production of recombinant human collagen
WO2009053985A1 (en) 2007-10-26 2009-04-30 Collplant Ltd. Methods of processing recombinant procollagen
AU2008345068A1 (en) * 2007-12-26 2009-07-09 Mark A. Pinsky Collagen formulations for improved skin care
CN104491845A (zh) 2008-04-18 2015-04-08 科尔普兰特有限公司 产生和使用原胶原的方法
EP2502939B1 (de) 2009-11-19 2016-01-27 Zhejiang University Unnatürliches collagen-artiges protein und seine verwendung
EP2504472A1 (de) 2009-11-24 2012-10-03 Collplant Ltd. Verfahren zur erzeugung von kollagenfasern
US9732321B2 (en) 2010-02-16 2017-08-15 The General Hospital Corporation Engineered craniofacial constructs with composite scaffold
EP2640877A2 (de) 2010-11-16 2013-09-25 Collplant Ltd. Kollagenstrukturen und herstellungsverfahren dafür
WO2013093921A1 (en) 2011-12-20 2013-06-27 Collplant Ltd. Collagen coated synthetic polymer fibers
WO2014147622A1 (en) 2013-03-21 2014-09-25 Collplant Ltd. Compositions comprising collagen and prp for tissue regeneration
EP3394095B1 (de) * 2015-12-23 2023-09-27 Phoenix Tissue Repair Inc. Kollagen-7-zusammensetzungen und verfahren zur verwendung davon
US11377490B2 (en) 2017-05-31 2022-07-05 Sichuan Clover Biopharmaceuticals, Inc Method for treating cancer using disulfide-linked trimeric 4-1BBL
CA3017328A1 (en) * 2017-07-18 2019-01-18 Suzanne Lee Biofabricated leather articles, and methods thereof
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
CN112334168A (zh) 2018-05-03 2021-02-05 科尔普兰特有限公司 真皮填充剂和其应用
GB2579036A (en) * 2018-11-15 2020-06-10 Rejuvenated Ltd Compositions comprising amino acids
CN113993885A (zh) 2019-04-12 2022-01-28 格尔托公司 重组弹性蛋白及其生产
FR3105792B1 (fr) 2019-12-26 2022-08-12 Michel Assor Matériau biocomposite collagène/matrice polymérique poreuse et son utilisation comme implant de réparation de lésions méniscales du genou et/ou de prévention ou de traitement de l’arthrose du genou
GB2610313B (en) 2020-01-24 2024-07-03 Geltor Inc Animal-free dietary collagen
WO2021229577A1 (en) 2020-05-12 2021-11-18 Collplant Ltd. Collagen as a delivery tool for metal-based anti-viral agents
WO2021249116A1 (en) 2020-06-10 2021-12-16 Sichuan Clover Biopharmaceuticals, Inc. Coronavirus vaccine compositions, methods, and uses thereof
WO2023194333A1 (en) 2022-04-04 2023-10-12 Swiftpharma Bv Recombinant spider silk-reinforced collagen proteins produced in plants and the use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956282A (en) * 1985-07-29 1990-09-11 Calgene, Inc. Mammalian peptide expression in plant cells
US5650554A (en) * 1991-02-22 1997-07-22 Sembiosys Genetics Inc. Oil-body proteins as carriers of high-value peptides in plants
CA2118113C (en) * 1991-02-22 2002-01-08 Maurice M. Moloney Oil-body proteins as carriers of high-value peptides in plants
JP3302017B2 (ja) * 1991-10-23 2002-07-15 トーマス・ジェファーソン・ユニバーシティ 組み換えｄｎａ合成システムにおけるヒトプロコラーゲン及びコラーゲンの合成
FR2685347A1 (fr) * 1991-12-23 1993-06-25 Univ Pasteur Procede biotechnologique d'obtention et de production microbienne d'oligomeres peptidiques comme substituts de la gelatine.
US5693506A (en) * 1993-11-16 1997-12-02 The Regents Of The University Of California Process for protein production in plants
US6713662B1 (en) * 1994-07-27 2004-03-30 Pharming Intellectual Property B.V. Production of collagen in the milk of transgenic mammals
WO1997004123A1 (en) * 1995-07-19 1997-02-06 Gel Tech Group Inc. Collagen compound production in plants
EP0939826A2 (de) * 1996-08-15 1999-09-08 Agrivax Incorporated Abgabe von tolerogenen antigenen über essbare pflanzen oder deren produkte

Also Published As

Publication number Publication date
DE69734528D1 (de) 2005-12-08
US20030096973A1 (en) 2003-05-22
WO1998027202A1 (fr) 1998-06-25
FR2757874A1 (fr) 1998-07-03
EP0951537B1 (de) 2005-11-02
US6617431B1 (en) 2003-09-09
JP2001507573A (ja) 2001-06-12
FR2757874B1 (fr) 2003-04-25
CA2274807A1 (fr) 1998-06-25
DE69734528T2 (de) 2006-07-27
EP0951537A1 (de) 1999-10-27
AU5563798A (en) 1998-07-15

Similar Documents

Publication Publication Date Title
ATE308614T1 (de) Durch pflanzen hergestelltes rekombinantes kollagen, verfahren zu ihrer herstellung und verwendung
ATE402260T1 (de) Rekombinante lactoferrin, verfahren zu ihrer herstellung mittels pflanzen und ihre verwendung
ATE355383T1 (de) Stress-gekoppeltes zellzyklus protein sowie dessen verwendung in pflanzen
DE3582093D1 (de) Verfahren zur herstellung von sauerstoff als nebenprodukt bei der erzeugung von turbinenstrom.
PT1124872E (pt) Pre-polimeros de poliuretano possuindo grupos terminais de alcoxissilano um processo para a sua preparacao assim como a sua utilizacao para a producao de massas vedantes
ATE553125T1 (de) Herstellung eines multimeren proteins durch zellfusionsverfahren
ATE470702T1 (de) Verfahren zur herstellung von permanenten humanen zelllinien
DE69414734D1 (de) Hydrierungskatalysator, Verfahren zur Herstellung dieses Katalysators und seine Verwendung bei der Herstellung von Wasserstoffperoxid
DE68907608D1 (de) Verfahren zur herstellung von lignin-peroxidase durch verwendung von nichtproliferierenden phanerochaete chryosporium-zellen.
DE69637510D1 (de) Verfahren zur herstellung temperatur-toleranter pflanzen
DE69332148D1 (de) Verwendung einer dna sequenz, kodierende für ein protein mit der fäligkeit oxalsäure abzubauen, zur genselektion
ATE234813T1 (de) Ketonperoxidderivate, ihre herstellung und verwendung
ATE408018T1 (de) Stress-resistenz als selektierbarer marker in transgenen pflanzen
DE69317656T2 (de) Inomer-zusammensetzungen, verfahren zur herstellung und verwendung davon, und umwandlungsverfahren dazu
ATE313632T1 (de) Durch pflanzen hergestellte rekombinante preduodenale lipase und abgeleitete polypeptide, verfahren zur herstellung und ihre verwendung
DE60234101D1 (de) Durch verstärktes wachstum charakterisierte pflanzen sowie für deren erzeugung geeignete verfahren und nukleinsäurekonstrukte
DE69838459D1 (de) Für den licht-überempfinlichkeitsphaenotyp kodierende nukleotidsequenzen von tomaten, dadurch kodierte proteine und deren verwendungen
DE68920358D1 (de) Verfahren zur Herstellung von Schwefelwasserstoff.
DE3486163D1 (de) Plasmide, verfahren zu ihrer herstellung, sie enthaltende mikroorganismen und methoden zur extrazellulaeren herstellung von xylanase durch zuechten dieser mikroorganismen.
DE60128796D1 (de) Verfahren zur herstellung von pflanzen mit erhöhter resistenz gegen wasserstress
ATA186592A (de) Nukleotidsequenz, die für den transforming growth faktor-beta2 kodiert, transforming growth faktor-beta2 sowie verfahren und zellen zur herstellung desselben
ATE225769T1 (de) Verfahren zur herstellung von arylmercaptanen durch hydrierung von diaryldisulfiden
GB9704305D0 (en) Procollagen assembly
ATE317018T1 (de) Verfahren zur herstellung von transgenen pflanzen,die ein protein exprimieren, das eine wasserstoff-peroxid prodzierende aktivität besitzt, mittels transformation durch agrobakterium rhizogenes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties